Drug Approval | August 12, 2021
Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
It’s an AB-rated generic therapeutic version of Durezol
It’s an AB-rated generic therapeutic version of Durezol
India business contributes to a stellar performance
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
This test is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in the upper and lower respiratory specimens from individuals suspected of COVID-19
The outlook for the US business remains good as respiratory pipeline (gAbraxane, gAdvair, gDulera) adds medium-term growth visibility.
The company has reported total income of Rs.19425.58 crores during FY ended March 31, 2021
Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO)
Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
The company has reported total income of Rs.14759 crores during the 9 months period ended December 31, 2020.
Subscribe To Our Newsletter & Stay Updated
